Friday, April 14, 2017

Defiant, Generic Drug Maker Continues to Raise Prices

Despite scrutiny from federal and state investigators, shares of Lannett Company are up 15 percent this year to date.
By GRETCHEN MORGENSON from NYT
Business Day

No comments:

Post a Comment